Thursday, 15 October 2026European Markets

Pound Falls to €1.13 Multi-Year Low as UK Budget Uncertainty Hits European Currency Markets

The British pound dropped 0.4% to €1.13, its lowest level since April 2023, while sliding 0.5% against the dollar to $1.3086. Mizuho Bank analysts predict GBP could break below $1.30 as fiscal uncertainty surrounding the UK's November 26 budget weighs on sentiment, creating ripple effects across European currency markets.

Pound Falls to €1.13 Multi-Year Low as UK Budget Uncertainty Hits European Currency Markets
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The British pound hit €1.13 on Tuesday, down 0.4% and marking its weakest position against the euro since April 2023. Against the dollar, sterling fell 0.5% to $1.3086 as markets braced for Chancellor Rachel Reeves' budget announcement on November 26.

Jordan Rochester at Mizuho Bank forecasts GBP could breach the $1.30 threshold. "Fiscal uncertainty is mounting," said Simon Phillips, managing director at No1 Currency. UK 30-year gilt yields climbed 4 basis points to 5.21%, the highest since August's 1998-level peak.

The pound's weakness stems from expectations of additional tax increases to address what Reeves calls a "black hole in public finances." UK inflation-linked bond auctions drew record demand—£69 billion in bids for £4.25 billion of debt, surpassing March's £67.5 billion record. Some 25% of UK gilts are tied to inflation, compared to roughly 10% in the US and France.

Neil Wilson, analyst at Saxo Markets, warned of "fiscal instability risk" affecting cross-border trade flows. European exporters face margin pressure as the stronger euro reduces competitiveness in UK markets. The euro zone's trade surplus with Britain, which reached €125 billion in 2025, could narrow if sterling continues weakening.

The Bloomberg Dollar Spot Index rose 0.1% after hitting 2022 lows, partially recovering on expectations around a new Federal Reserve chair appointment. This dollar stabilization provided limited relief to European currencies broadly.

UK political turmoil compounds currency volatility. Prime Minister Keir Starmer faces alleged leadership challenges, with Health Secretary Wes Streeting denying coup plotting while criticizing "toxic" Downing Street culture. Home Secretary Shabana Mahmood has also faced leadership speculation.

European equity markets showed resilience despite currency swings. The Stoxx 600 gained 0.6% to a record 583.4 points. France's CAC 40 rose 0.7% and Germany's DAX climbed 0.9%, suggesting investors are separating UK fiscal concerns from broader European growth prospects.

Kathleen Brooks, research director at XTB, noted gilt yield movements indicate markets are pricing in sustained UK borrowing costs. Mike Riddell at Fidelity Strategic Bond Fund called gilts the "top performer globally over recent months," though Julian Jessop at the Institute of Economic Affairs sees "no sign bond markets are rattled."

Currency traders are monitoring whether the pound's decline accelerates if the November 26 budget reveals larger-than-expected tax increases or spending cuts.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com